Skip to main content

iwCLL 2023 Main banner

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Katharine L. Lewis, MBBS

Sir Charles Gairdner Hospital, Nedlands, WA, Australia and Linear Clinical Research, Australia

N/A

Poster(s):

2008 - BRUIN CLL-314: A phase 3, open-label, randomized study of pirtobrutinib versus ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (trial in progress)